Volmaro 5 mg &10 mg FC Tablets
PDF Leaflet Revision Date: 30 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of pulmonary arterial hypertension (PAH).
Dosage (summary)
5 mg once daily, may increase to 10 mg if tolerated.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; breastfeeding not recommended.
Key Drug Interactions
- Ciclosporin A
- Ketoconazole
- Rifampicin
- Warfarin
Contraindications
- Pregnancy
- Breastfeeding
- Severe hepatic impairment
Common side effects
- Peripheral oedema
- Headache
- Anaemia
- Dizziness
Counselling Points
- Avoid in pregnancy; reliable contraception required.
- Monitor for signs of hepatic injury.
- Report any signs of anaemia.
Serious warnings
- Hepatic injury
- Autoimmune hepatitis
- Fluid retention
Important Disclaimer
The Volmaro 5 mg &10 mg FC Tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
